Isolated Lung Perfusion for Pulmonary Metastases.

Area of Science:

• Surgical Oncology
• Pharmacology
• Thoracic Surgery

Background:

• Pulmonary metastases pose a significant clinical challenge.
• Systemic chemotherapy often leads to dose-limiting toxicities.
• Targeted delivery of chemotherapeutics to the lungs is desirable.

Purpose of the Study:

• To evaluate the safety and efficacy of Isolated Lung Perfusion (ILP) for treating pulmonary metastases.
• To review the chemotherapeutic agents utilized in ILP.
• To assess the clinical outcomes of ILP in human trials.

Main Methods:

• Isolated Lung Perfusion (ILP) surgical technique.
• Administration of high-dose chemotherapy directly into the pulmonary vasculature.
• Review of phase I clinical trials and studied chemotherapeutic agents.

Main Results:

• ILP can be safely performed in human patients.
• A variety of chemotherapeutic agents have been studied in ILP.
• Clinical results and long-term survival rates are mixed and generally poor.

Conclusions:

• ILP is a feasible method for localized lung cancer treatment.
• Further research is needed to improve ILP efficacy and patient survival.
• Optimization of chemotherapeutic agents and delivery strategies is warranted.